Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2026.02.009 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Samantha Gregoire und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Department of Dermatology, Boston, Massachusetts; University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffal…. Hauptthemen laut MEDLINE: Spironolactone, Hyperkalemia, Mineralocorticoid Receptor Antagonists, Skin Diseases. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Spironolactone is widely used in dermatology. While routine potassium monitoring is no longer recommended in young, healthy females taking spironolactone for acne, hyperkalemia incidence, risk factors, and monitoring necessity in older females is unclear. OBJECTIVE: To determine hyperkalemia incidence in females aged ≥45 taking spironolactone for dermatologic conditions. METHODS: In this retrospective cohort study, 1197 Mass General Brigham medical records from January 1, 2015 through February 25, 2025 were reviewed; 398 cases were analyzed. RESULTS: Hyperkalemia incidence was 10.1% (40/398) and more commonly observed in older patients (age ≥65: 22.4% versus ages 45-64: 7.9%) and those with ≥1 predisposing comorbidity (medically complex: 14.7% versus healthy: 7.3%). Healthy females aged 45-64 were least affected (6.3%). Patients age ≥65 with ≥1 predisposing comorbidity had the highest incidence (28.1%). Hyperkalemia was generally mild (97.5%), asymptomatic (85%), and did not impact clinical management (62.5%). LIMITATIONS: Limitations include retrospective design and lack of comparator group. CONCLUSION: Overall hyperkalemia risk in females aged ≥45 is higher than in younger patients and increased further in specific subpopulations. Hyperkalemia is generally mild and prescription modification is uncommon. While spironolactone use is safe for most patients, monitoring guidelines should be clarified to ensure optimal management in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York.
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania.
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
- Brigham and Women's Department of Dermatology, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Gregoire, S., Dewey, E., Sanchez, K., Biba, U., Ershadi, S., Cheng, D., Acevedo-Fontanez, L., Bensellam, N., Barbieri, J. S., & Mostaghimi, A. (2026). Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.02.009
Vancouver
Gregoire S, Dewey E, Sanchez K, Biba U, Ershadi S, Cheng D, et al. Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.02.009
BibTeX
@article{Gregoire2026,
author = {Gregoire, Samantha and Dewey, Eliza and Sanchez, Katherine and Biba, Ursula and Ershadi, Sherry and Cheng, Debby and Acevedo-Fontanez, Lorena and Bensellam, Nora and Barbieri, John S and Mostaghimi, Arash},
title = {Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.02.009}
}
EUVIMED